TESTOSTERONE CYPIONATE

TESTOSTERONE CYPIONATE was reported 9049 times

These side effects are most commonly reported by patients taking TESTOSTERONE CYPIONATE:

# Side effect Count
0 MYOCARDIAL INFARCTION 949
1 CEREBROVASCULAR ACCIDENT 685
2 DRUG INEFFECTIVE 625
3 DEEP VEIN THROMBOSIS 622
4 PULMONARY EMBOLISM 558
5 PAIN 491
6 FATIGUE 487
7 PRODUCT DOSE OMISSION ISSUE 399
8 ANXIETY 369
9 THROMBOSIS 347
10 PRODUCT DEPOSIT 325
11 INJECTION SITE PAIN 317
12 OFF LABEL USE 316
13 ASTHENIA 269
14 LIQUID PRODUCT PHYSICAL ISSUE 255
15 DYSPNOEA 254
16 HEADACHE 251
17 DEPRESSION 246
18 POOR QUALITY PRODUCT ADMINISTERED 244
19 ACUTE MYOCARDIAL INFARCTION 231
20 CARDIOVASCULAR DISORDER 225
21 NAUSEA 216
22 CARDIAC FAILURE CONGESTIVE 204
23 DIARRHOEA 180
24 FEELING ABNORMAL 180
25 DIZZINESS 164
26 PRODUCT USE ISSUE 164
27 PRODUCT QUALITY ISSUE 162
28 PAIN IN EXTREMITY 159
29 ARTHRALGIA 158
30 HYPERTENSION 154
31 CHEST PAIN 148
32 CARDIAC DISORDER 144
33 MALAISE 143
34 CORONARY ARTERY DISEASE 141
35 PRODUCT USE IN UNAPPROVED INDICATION 135
36 RASH 134
37 INFARCTION 133
38 WEIGHT DECREASED 131
39 EMOTIONAL DISTRESS 129
40 QUALITY OF LIFE DECREASED 129
41 ISCHAEMIA 127
42 BLOOD TESTOSTERONE DECREASED 125
43 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 125
44 COUGH 121
45 ATRIAL FIBRILLATION 116
46 DEATH 116
47 FALL 116
48 PNEUMONIA 116
49 WEIGHT INCREASED 116
50 MULTIPLE USE OF SINGLE-USE PRODUCT 115
51 INSOMNIA 114
52 CONDITION AGGRAVATED 113
53 BACK PAIN 110
54 INJECTION SITE SWELLING 110
55 VOMITING 108
56 PRURITUS 107
57 GAIT DISTURBANCE 105
58 TRANSIENT ISCHAEMIC ATTACK 104
59 INCORRECT DOSE ADMINISTERED 101
60 MUSCLE SPASMS 99
61 SOMNOLENCE 95
62 MYALGIA 94
63 INTENTIONAL PRODUCT USE ISSUE 93
64 ECONOMIC PROBLEM 92
65 COVID-19 87
66 ANHEDONIA 86
67 AMNESIA 83
68 INJECTION SITE ERYTHEMA 83
69 PRODUCT ADMINISTRATION ERROR 83
70 BLOOD PRESSURE INCREASED 82
71 PERIPHERAL SWELLING 82
72 POLYCYTHAEMIA 82
73 MEMORY IMPAIRMENT 81
74 PYREXIA 80
75 SURGERY 78
76 ACUTE KIDNEY INJURY 76
77 HYPERSENSITIVITY 76
78 HYPOAESTHESIA 76
79 INJURY 76
80 BLOOD TESTOSTERONE INCREASED 73
81 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73
82 CONSTIPATION 72
83 DECREASED APPETITE 72
84 SLEEP APNOEA SYNDROME 72
85 ERECTILE DYSFUNCTION 70
86 INFECTION 70
87 BLOOD GLUCOSE INCREASED 68
88 BURNING SENSATION 68
89 BALANCE DISORDER 66
90 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65
91 CHRONIC KIDNEY DISEASE 64
92 CONFUSIONAL STATE 64
93 INJECTION SITE MASS 64
94 RENAL FAILURE 64
95 CARDIAC ARREST 63
96 CELLULITIS 63
97 PRODUCT WITH QUALITY ISSUE ADMINISTERED 63
98 NASOPHARYNGITIS 62
99 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 62
100 ABDOMINAL DISCOMFORT 61
101 ACTIVITIES OF DAILY LIVING IMPAIRED 60
102 RECALLED PRODUCT ADMINISTERED 60
103 TREMOR 60
104 SINUSITIS 59
105 MUSCULAR WEAKNESS 57
106 POOR QUALITY DRUG ADMINISTERED 57
107 SUICIDAL IDEATION 57
108 NEUROPATHY PERIPHERAL 55
109 PARAESTHESIA 55
110 ABDOMINAL PAIN UPPER 54
111 ERYTHEMA 54
112 HYPERHIDROSIS 54
113 PRODUCT PACKAGING QUANTITY ISSUE 54
114 DEHYDRATION 53
115 THERAPEUTIC RESPONSE UNEXPECTED 53
116 UNDERDOSE 53
117 INTENTIONAL PRODUCT MISUSE 52
118 DRUG ABUSE 51
119 URTICARIA 51
120 VISION BLURRED 51
121 ABDOMINAL PAIN 50
122 ILLNESS 50
123 LIBIDO DECREASED 50
124 PRODUCT ADMINISTRATION INTERRUPTED 50
125 NO ADVERSE EVENT 49
126 PRE-EXISTING CONDITION IMPROVED 49
127 STRESS 49
128 DRUG DOSE OMISSION 48
129 HYPOTENSION 48
130 IMPAIRED WORK ABILITY 48
131 ISCHAEMIC STROKE 48
132 LETHARGY 48
133 PRODUCT DOSE OMISSION 48
134 ANAEMIA 47
135 HOSPITALISATION 47
136 IDIOPATHIC INTRACRANIAL HYPERTENSION 47
137 SEIZURE 47
138 SLEEP DISORDER 47
139 INFLUENZA 46
140 MIGRAINE 46
141 LOSS OF CONSCIOUSNESS 45
142 PRODUCT STORAGE ERROR 45
143 PRODUCT SUBSTITUTION ISSUE 45
144 DIABETES MELLITUS 44
145 DRUG EFFECT DECREASED 44
146 FEAR 44
147 CHEST DISCOMFORT 42
148 PALPITATIONS 42
149 SYNCOPE 42
150 BRONCHITIS 41
151 DRUG HYPERSENSITIVITY 41
152 GASTROOESOPHAGEAL REFLUX DISEASE 41
153 HAEMATOCRIT INCREASED 40
154 MENTAL DISORDER 40
155 ALOPECIA 39
156 ANGINA PECTORIS 39
157 CARDIAC FAILURE 39
158 DISTURBANCE IN ATTENTION 39
159 INTENTIONAL DOSE OMISSION 39
160 OVERDOSE 39
161 PROSTATIC DISORDER 39
162 URINARY TRACT INFECTION 39
163 VISUAL IMPAIRMENT 39
164 ABDOMINAL DISTENSION 38
165 ARTHRITIS 38
166 BLOOD CREATININE INCREASED 38
167 DERMATITIS ATOPIC 38
168 DRUG ADMINISTERED AT INAPPROPRIATE SITE 38
169 DYSPEPSIA 38
170 MOBILITY DECREASED 38
171 NIGHT SWEATS 38
172 UNEVALUABLE EVENT 38
173 CEREBRAL INFARCTION 36
174 IRRITABILITY 36
175 PRODUCT GEL FORMATION 36
176 BLOOD CHOLESTEROL INCREASED 35
177 GENERAL PHYSICAL HEALTH DETERIORATION 35
178 INCORRECT DRUG ADMINISTRATION DURATION 35
179 SWELLING 35
180 ANGER 34
181 DISCOMFORT 34
182 EMOTIONAL DISORDER 34
183 METAPLASIA 34
184 NEPHROLITHIASIS 34
185 SPEECH DISORDER 34
186 ACNE 33
187 OSTEOPOROSIS 33
188 RENAL IMPAIRMENT 33
189 ACCIDENTAL EXPOSURE TO PRODUCT 32
190 ASTHMA 32
191 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32
192 DEPRESSED MOOD 32
193 FLUSHING 32
194 HOT FLUSH 32
195 PRODUCT COLOUR ISSUE 32
196 SEPSIS 32
197 BONE DENSITY DECREASED 31
198 DYSPHAGIA 31
199 FEELING HOT 31
200 HEART RATE INCREASED 31
201 INJECTION SITE REACTION 31
202 OEDEMA PERIPHERAL 31
203 PHYSICAL DISABILITY 31
204 PROSTATE CANCER 31
205 ACUTE RESPIRATORY FAILURE 30
206 HAEMOGLOBIN INCREASED 30
207 LUNG DISORDER 30
208 MUSCULOSKELETAL PAIN 30
209 TACHYCARDIA 30
210 CHILLS 29
211 PRODUCT USE COMPLAINT 29
212 ROAD TRAFFIC ACCIDENT 29
213 CONTUSION 28
214 DYSURIA 28
215 INJECTION SITE BRUISING 28
216 NASAL CONGESTION 28
217 SEASONAL ALLERGY 28
218 UPPER RESPIRATORY TRACT INFECTION 28
219 ARRHYTHMIA 27
220 BRAIN INJURY 27
221 CARDIOMYOPATHY 27
222 COGNITIVE DISORDER 27
223 DRY SKIN 27
224 HAEMORRHAGE 27
225 INFLUENZA LIKE ILLNESS 27
226 INJECTION SITE WARMTH 27
227 PRESCRIBED OVERDOSE 27
228 ADVERSE DRUG REACTION 26
229 BLINDNESS 26
230 DRUG INTERACTION 26
231 EXPIRED PRODUCT ADMINISTERED 26
232 HEART RATE IRREGULAR 26
233 INCORRECT PRODUCT ADMINISTRATION DURATION 26
234 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26
235 INJECTION SITE PRURITUS 26
236 OSTEOARTHRITIS 26
237 PRODUCT CONTAMINATION PHYSICAL 26
238 PSORIASIS 26
239 CARDIOMEGALY 25
240 DRUG DEPENDENCE 25
241 EYE PAIN 25
242 FLUID RETENTION 25
243 LIMB INJURY 25
244 MUSCULOSKELETAL STIFFNESS 25
245 OSTEOPENIA 25
246 THERAPEUTIC PRODUCT EFFECT DECREASED 25
247 THERAPY INTERRUPTED 25
248 ASPARTATE AMINOTRANSFERASE INCREASED 24
249 DYSPHONIA 24
250 EPISTAXIS 24
251 HEMIPARESIS 24
252 INTERVERTEBRAL DISC PROTRUSION 24
253 JOINT SWELLING 24
254 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24
255 NECK PAIN 24
256 OEDEMA 24
257 PLEURAL EFFUSION 24
258 SINUS DISORDER 24
259 THROMBOPHLEBITIS SUPERFICIAL 24
260 VERTIGO 24
261 AGGRESSION 23
262 AGITATION 23
263 BLOOD TESTOSTERONE ABNORMAL 23
264 DECREASED ACTIVITY 23
265 DRY MOUTH 23
266 DYSGEUSIA 23
267 GASTROINTESTINAL HAEMORRHAGE 23
268 HEMIPLEGIA 23
269 INJECTION SITE NODULE 23
270 OROPHARYNGEAL PAIN 23
271 PRODUCT PHYSICAL ISSUE 23
272 ADVERSE EVENT 22
273 BENIGN PROSTATIC HYPERPLASIA 22
274 BRAIN FOG 22
275 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22
276 HYPERSOMNIA 22
277 HYPOTHYROIDISM 22
278 RENAL DISORDER 22
279 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22
280 TINNITUS 22
281 ANAPHYLACTIC REACTION 21
282 CARDIO-RESPIRATORY ARREST 21
283 CARDIOGENIC SHOCK 21
284 INJECTION SITE INFECTION 21
285 NEURALGIA 21
286 PANCREATITIS 21
287 PSORIATIC ARTHROPATHY 21
288 RESPIRATORY FAILURE 21
289 RHEUMATOID ARTHRITIS 21
290 THERAPEUTIC RESPONSE DECREASED 21
291 ACUTE CORONARY SYNDROME 20
292 ALANINE AMINOTRANSFERASE INCREASED 20
293 ANGINA UNSTABLE 20
294 CORONARY ARTERY OCCLUSION 20
295 DISABILITY 20
296 EMBOLISM 20
297 EYE IRRITATION 20
298 INJECTION SITE INFLAMMATION 20
299 PLATELET COUNT DECREASED 20
300 POST-TRAUMATIC STRESS DISORDER 20
301 PRODUCTIVE COUGH 20
302 BLOOD POTASSIUM DECREASED 19
303 BONE PAIN 19
304 DISEASE RECURRENCE 19
305 FEELING COLD 19
306 HYPERLIPIDAEMIA 19
307 INJECTION SITE INDURATION 19
308 PRODUCT CONTAMINATION 19
309 PRODUCT PRESCRIBING ISSUE 19
310 PULMONARY OEDEMA 19
311 RED BLOOD CELL COUNT INCREASED 19
312 SKIN LESION 19
313 SOCIAL PROBLEM 19
314 STAPHYLOCOCCAL INFECTION 19
315 SUSPECTED PRODUCT TAMPERING 19
316 TASTE DISORDER 19
317 THROMBOCYTOPENIA 19
318 WHITE BLOOD CELL COUNT DECREASED 19
319 BLINDNESS UNILATERAL 18
320 BLISTER 18
321 CYST 18
322 DRUG INTOLERANCE 18
323 GASTROINTESTINAL DISORDER 18
324 HYPOXIA 18
325 ILL-DEFINED DISORDER 18
326 INJECTION SITE HAEMORRHAGE 18
327 LOSS OF LIBIDO 18
328 MUSCLE ATROPHY 18
329 PANIC ATTACK 18
330 SKIN EXFOLIATION 18
331 THERAPY NON-RESPONDER 18
332 VIRAL INFECTION 18
333 WHEEZING 18
334 WITHDRAWAL SYNDROME 18
335 ARTHROPATHY 17
336 BLOOD PRESSURE DECREASED 17
337 DRUG EFFECT LESS THAN EXPECTED 17
338 DYSSTASIA 17
339 EMBOLISM VENOUS 17
340 HEPATIC ENZYME INCREASED 17
341 LACRIMATION INCREASED 17
342 MOOD SWINGS 17
343 OXYGEN SATURATION DECREASED 17
344 POLLAKIURIA 17
345 PRODUCT TAMPERING 17
346 RECTAL HAEMORRHAGE 17
347 TYPE 2 DIABETES MELLITUS 17
348 APHASIA 16
349 ARTERIOSCLEROSIS 16
350 ATRIAL FLUTTER 16
351 CEREBRAL HAEMORRHAGE 16
352 CONJUNCTIVITIS 16
353 CORONARY ARTERY THROMBOSIS 16
354 ECZEMA 16
355 EXPOSURE VIA SKIN CONTACT 16
356 GYNAECOMASTIA 16
357 HALLUCINATION 16
358 HYPOGONADISM 16
359 IMPAIRED GASTRIC EMPTYING 16
360 INTRACRANIAL PRESSURE INCREASED 16
361 LOCALISED INFECTION 16
362 LYMPHADENOPATHY 16
363 MOOD ALTERED 16
364 NERVOUSNESS 16
365 NEUTROPENIA 16
366 OCULAR HYPERAEMIA 16
367 PRODUCT PHYSICAL CONSISTENCY ISSUE 16
368 RASH MACULAR 16
369 RHABDOMYOLYSIS 16
370 SEXUAL DYSFUNCTION 16
371 TREATMENT NONCOMPLIANCE 16
372 CATARACT 15
373 COLD SWEAT 15
374 DRUG WITHDRAWAL SYNDROME 15
375 HEAD INJURY 15
376 HERPES ZOSTER 15
377 INCORRECT PRODUCT STORAGE 15
378 INJECTION SITE RASH 15
379 INTESTINAL OBSTRUCTION 15
380 MENTAL STATUS CHANGES 15
381 MULTIPLE SCLEROSIS RELAPSE 15
382 OSTEONECROSIS 15
383 PRODUCT CLOSURE ISSUE 15
384 PULMONARY INFARCTION 15
385 RASH PRURITIC 15
386 RESTLESS LEGS SYNDROME 15
387 SCAR 15
388 SLUGGISHNESS 15
389 SPINAL OPERATION 15
390 STOMATITIS 15
391 BACK DISORDER 14
392 CARDIAC FAILURE ACUTE 14
393 CARDIAC VENTRICULAR THROMBOSIS 14
394 CROHN^S DISEASE 14
395 DISEASE PROGRESSION 14
396 DRUG DISPENSING ERROR 14
397 DRUG EFFECT INCOMPLETE 14
398 FLATULENCE 14
399 HAIR GROWTH ABNORMAL 14
400 HEART INJURY 14
401 HORMONE LEVEL ABNORMAL 14
402 HYPOKALAEMIA 14
403 NEOPLASM MALIGNANT 14
404 PERICARDIAL EFFUSION 14
405 POOR QUALITY SLEEP 14
406 PRIAPISM 14
407 PROSTATIC SPECIFIC ANTIGEN INCREASED 14
408 PULMONARY THROMBOSIS 14
409 RHINORRHOEA 14
410 RIB FRACTURE 14
411 SKIN DISCOLOURATION 14
412 SKIN ULCER 14
413 SOMNAMBULISM 14
414 SUPRAVENTRICULAR TACHYCARDIA 14
415 TENDON RUPTURE 14
416 THERAPEUTIC RESPONSE SHORTENED 14
417 THERAPY CESSATION 14
418 THINKING ABNORMAL 14
419 THIRST 14
420 THROAT TIGHTNESS 14
421 VENTRICULAR FIBRILLATION 14
422 WALKING AID USER 14
423 ADRENAL INSUFFICIENCY 13
424 ARTERIAL OCCLUSIVE DISEASE 13
425 ARTERIOSCLEROSIS CORONARY ARTERY 13
426 BIPOLAR DISORDER 13
427 BLOOD GLUCOSE DECREASED 13
428 BLOOD TRIGLYCERIDES INCREASED 13
429 CORONARY BYPASS THROMBOSIS 13
430 DIPLOPIA 13
431 DIVERTICULITIS 13
432 DRY EYE 13
433 DYSARTHRIA 13
434 DYSGRAPHIA 13
435 DYSPNOEA EXERTIONAL 13
436 EYE SWELLING 13
437 HAEMATURIA 13
438 HYPOACUSIS 13
439 HYPONATRAEMIA 13
440 IMPAIRED QUALITY OF LIFE 13
441 INJECTION SITE DISCOMFORT 13
442 INJECTION SITE URTICARIA 13
443 ISCHAEMIC CARDIOMYOPATHY 13
444 MOVEMENT DISORDER 13
445 NERVE INJURY 13
446 PARAESTHESIA ORAL 13
447 PARANOIA 13
448 PARKINSON^S DISEASE 13
449 URINARY RETENTION 13
450 VENTRICULAR EXTRASYSTOLES 13
451 VENTRICULAR TACHYCARDIA 13
452 ABNORMAL BEHAVIOUR 12
453 APATHY 12
454 BLOOD BILIRUBIN INCREASED 12
455 CHOLELITHIASIS 12
456 DEAFNESS 12
457 DEVICE ISSUE 12
458 FEBRILE NEUTROPENIA 12
459 FIBROMYALGIA 12
460 FOOT FRACTURE 12
461 GASTROENTERITIS VIRAL 12
462 HAEMATOMA 12
463 HAEMOGLOBIN DECREASED 12
464 HUNGER 12
465 HYPERCOAGULATION 12
466 HYPERKALAEMIA 12
467 INFLAMMATION 12
468 INFUSION RELATED REACTION 12
469 JOINT INJURY 12
470 KNEE ARTHROPLASTY 12
471 MALIGNANT MELANOMA 12
472 MUSCLE TIGHTNESS 12
473 NIGHTMARE 12
474 NOCTURIA 12
475 OBESITY 12
476 PLASMA CELL MYELOMA 12
477 POLYCYTHAEMIA VERA 12
478 PRESYNCOPE 12
479 PRODUCT DOSE OMISSION IN ERROR 12
480 PROSTATOMEGALY 12
481 RENAL CYST 12
482 RESPIRATORY TRACT INFECTION 12
483 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12
484 SUSPECTED COUNTERFEIT PRODUCT 12
485 SUSPECTED PRODUCT CONTAMINATION 12
486 VITAMIN D DEFICIENCY 12
487 WHITE BLOOD CELL COUNT INCREASED 12
488 ABNORMAL DREAMS 11
489 AORTIC ANEURYSM 11
490 BLOOD PRESSURE ABNORMAL 11
491 BONE DISORDER 11
492 BRADYCARDIA 11
493 BURSITIS 11
494 DELUSION 11
495 GLOMERULAR FILTRATION RATE DECREASED 11
496 GLYCOSYLATED HAEMOGLOBIN INCREASED 11
497 HAEMORRHOIDS 11
498 HIP ARTHROPLASTY 11
499 IMMUNE SYSTEM DISORDER 11
500 INTERVERTEBRAL DISC DEGENERATION 11
501 LEFT VENTRICULAR DYSFUNCTION 11
502 MANIA 11
503 MEDICATION ERROR 11
504 MENTAL IMPAIRMENT 11
505 MIDDLE INSOMNIA 11
506 NEEDLE ISSUE 11
507 NERVOUS SYSTEM DISORDER 11
508 POST PROCEDURAL COMPLICATION 11
509 PRODUCT PREPARATION ERROR 11
510 PRODUCT SUPPLY ISSUE 11
511 RENAL INJURY 11
512 SECONDARY HYPOGONADISM 11
513 SENSORY LOSS 11
514 SEPTIC SHOCK 11
515 SINUS CONGESTION 11
516 SKIN DISORDER 11
517 SUICIDE ATTEMPT 11
518 TENDERNESS 11
519 URINARY INCONTINENCE 11
520 VISUAL FIELD DEFECT 11
521 WHEELCHAIR USER 11
522 ABASIA 10
523 BLOOD OESTROGEN INCREASED 10
524 BLOOD UREA INCREASED 10
525 CHOKING 10
526 CORONARY ARTERY STENOSIS 10
527 DRUG ADMINISTRATION ERROR 10
528 EAR INFECTION 10
529 EXOSTOSIS 10
530 EXTRA DOSE ADMINISTERED 10
531 FACIAL PARALYSIS 10
532 FLUID OVERLOAD 10
533 GOUT 10
534 HAEMATOCHEZIA 10
535 HEART RATE DECREASED 10
536 INFUSION SITE PAIN 10
537 INSURANCE ISSUE 10
538 INTRACARDIAC THROMBUS 10
539 LOSS OF EMPLOYMENT 10
540 MULTIPLE FRACTURES 10
541 MUSCLE SPASTICITY 10
542 MUSCULOSKELETAL CHEST PAIN 10
543 MUSCULOSKELETAL DISCOMFORT 10
544 MUSCULOSKELETAL DISORDER 10
545 PAIN IN JAW 10
546 PERICARDITIS 10
547 PRODUCT DISPENSING ERROR 10
548 SCIATICA 10
549 SEDATION 10
550 SNORING 10
551 SPINAL OSTEOARTHRITIS 10
552 SQUAMOUS CELL CARCINOMA 10
553 SUDDEN CARDIAC DEATH 10
554 SWELLING FACE 10
555 TESTICULAR ATROPHY 10
556 THROAT IRRITATION 10
557 THYROID DISORDER 10
558 AORTIC STENOSIS 9
559 BACK INJURY 9
560 BLOOD MAGNESIUM DECREASED 9
561 BLOOD SODIUM DECREASED 9
562 CARPAL TUNNEL SYNDROME 9
563 CONTRAINDICATED PRODUCT ADMINISTERED 9
564 COORDINATION ABNORMAL 9
565 CRYING 9
566 DECREASED INTEREST 9
567 DELIRIUM 9
568 DISORIENTATION 9
569 DYSKINESIA 9
570 ENERGY INCREASED 9
571 ESSENTIAL HYPERTENSION 9
572 EXERCISE TOLERANCE DECREASED 9
573 FEELING DRUNK 9
574 FUNGAL INFECTION 9
575 GLAUCOMA 9
576 HEAD DISCOMFORT 9
577 HEPATIC ADENOMA 9
578 HYPOGLYCAEMIA 9
579 INCORRECT ROUTE OF DRUG ADMINISTRATION 9
580 INFUSION SITE ERYTHEMA 9
581 INJECTION SITE DISCOLOURATION 9
582 INSULIN-LIKE GROWTH FACTOR INCREASED 9
583 KIDNEY INFECTION 9
584 LABORATORY TEST ABNORMAL 9
585 LOW DENSITY LIPOPROTEIN INCREASED 9
586 MUSCLE STRAIN 9
587 MYOCARDIAL ISCHAEMIA 9
588 ORAL PAIN 9
589 PANCYTOPENIA 9
590 PARALYSIS 9
591 PERSONALITY CHANGE 9
592 PHOTOPHOBIA 9
593 PNEUMONITIS 9
594 PRODUCT COMPLAINT 9
595 PRODUCT CONTAINER SEAL ISSUE 9
596 PSYCHOMOTOR HYPERACTIVITY 9
597 PULMONARY FIBROSIS 9
598 PULMONARY MASS 9
599 RED CELL DISTRIBUTION WIDTH INCREASED 9
600 RENAL TUBULAR NECROSIS 9
601 ROTATOR CUFF SYNDROME 9
602 SKIN INFECTION 9
603 SPINAL FUSION SURGERY 9
604 TEMPERATURE INTOLERANCE 9
605 TOOTH DISORDER 9
606 WEIGHT FLUCTUATION 9
607 AFFECT LABILITY 8
608 ANGIOPATHY 8
609 ANOSMIA 8
610 APPLICATION SITE PAIN 8
611 ASCITES 8
612 BLOOD CALCIUM DECREASED 8
613 BLOOD CREATINE PHOSPHOKINASE INCREASED 8
614 BLOOD IRON DECREASED 8
615 BLOOD POTASSIUM INCREASED 8
616 BLOOD TEST ABNORMAL 8
617 BLOOD THYROID STIMULATING HORMONE DECREASED 8
618 CEREBRAL DISORDER 8
619 CHROMATURIA 8
620 COLITIS ULCERATIVE 8
621 CONVULSION 8
622 CYSTITIS 8
623 DEVICE LEAKAGE 8
624 EMPHYSEMA 8
625 ENCEPHALOPATHY 8
626 END STAGE RENAL DISEASE 8
627 ESSENTIAL TREMOR 8
628 FEEDING DISORDER 8
629 HALLUCINATION, AUDITORY 8
630 HEPATIC STEATOSIS 8
631 HERNIA 8
632 HYPERAESTHESIA 8
633 HYPERPROLACTINAEMIA 8
634 IMPAIRED HEALING 8
635 INCREASED APPETITE 8
636 INITIAL INSOMNIA 8
637 INJECTION SITE IRRITATION 8
638 KNEE OPERATION 8
639 LIMB DISCOMFORT 8
640 LIVER FUNCTION TEST ABNORMAL 8
641 MAJOR DEPRESSION 8
642 MALIGNANT NEOPLASM PROGRESSION 8
643 MYOCARDITIS 8
644 NASAL SEPTUM DEVIATION 8
645 OBSESSIVE-COMPULSIVE DISORDER 8
646 OSTEOMYELITIS 8
647 PAPILLOEDEMA 8
648 PERIPHERAL ARTERY THROMBOSIS 8
649 PHARMACEUTICAL PRODUCT COMPLAINT 8
650 PNEUMONIA ASPIRATION 8
651 POST PROCEDURAL INFECTION 8
652 POSTOPERATIVE WOUND INFECTION 8
653 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8
654 PROCEDURAL PAIN 8
655 PRODUCT CONTAINER ISSUE 8
656 PRODUCT FORMULATION ISSUE 8
657 PRODUCT LABEL ISSUE 8
658 PRODUCT PREPARATION ISSUE 8
659 PROSTATITIS 8
660 PSYCHOTIC DISORDER 8
661 SKIN CANCER 8
662 SKIN ODOUR ABNORMAL 8
663 THROMBOPHLEBITIS 8
664 TOOTH INFECTION 8
665 TREATMENT FAILURE 8
666 VITAMIN D DECREASED 8
667 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8
668 ABSCESS 7
669 ACUTE RESPIRATORY DISTRESS SYNDROME 7
670 AFFECTIVE DISORDER 7
671 ANKLE FRACTURE 7
672 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7
673 AUTOIMMUNE THYROIDITIS 7
674 BASAL CELL CARCINOMA 7
675 BODY HEIGHT DECREASED 7
676 BONE DEMINERALISATION 7
677 BREAST CANCER 7
678 CANDIDA INFECTION 7
679 CAROTID ARTERY STENOSIS 7
680 CEREBRAL THROMBOSIS 7
681 CEREBROVASCULAR DISORDER 7
682 COLITIS 7
683 COMPLETED SUICIDE 7
684 DEFORMITY 7
685 DEVICE BREAKAGE 7
686 DEVICE DISLOCATION 7
687 DEVICE MALFUNCTION 7
688 DRUG-INDUCED LIVER INJURY 7
689 ERECTION INCREASED 7
690 EYE DISORDER 7
691 EYE PRURITUS 7
692 FAMILY STRESS 7
693 FEELING JITTERY 7
694 FOOD ALLERGY 7
695 FREQUENT BOWEL MOVEMENTS 7
696 FURUNCLE 7
697 GAIT INABILITY 7
698 HEPATIC FAILURE 7
699 HICCUPS 7
700 HIGH DENSITY LIPOPROTEIN DECREASED 7
701 HYPOGONADISM MALE 7
702 HYPOTHALAMO-PITUITARY DISORDER 7
703 IMPAIRED DRIVING ABILITY 7
704 INCORRECT DRUG ADMINISTRATION RATE 7
705 INFUSION SITE SWELLING 7
706 INJECTION SITE CELLULITIS 7
707 LACUNAR INFARCTION 7
708 LIP SWELLING 7
709 LIVER DISORDER 7
710 MICTURITION URGENCY 7
711 MOTOR DYSFUNCTION 7
712 MULTIPLE SCLEROSIS 7
713 MUSCLE TWITCHING 7
714 NEOPLASM 7
715 NEUTROPHIL COUNT DECREASED 7
716 OESOPHAGITIS 7
717 OESTRADIOL INCREASED 7
718 ONYCHOMYCOSIS 7
719 OROPHARYNGEAL DISCOMFORT 7
720 ORTHOSTATIC HYPOTENSION 7
721 PHARYNGEAL SWELLING 7
722 PHARYNGITIS 7
723 PRODUCT PRESCRIBING ERROR 7
724 PROSTATE INFECTION 7
725 PULMONARY HYPERTENSION 7
726 RASH ERYTHEMATOUS 7
727 RESTLESSNESS 7
728 RETINAL ARTERY OCCLUSION 7
729 RETINAL DETACHMENT 7
730 SCRATCH 7
731 SKIN HAEMORRHAGE 7
732 SUBCUTANEOUS ABSCESS 7
733 SWOLLEN TONGUE 7
734 TESTICULAR DISORDER 7
735 TOOTH LOSS 7
736 TOXICITY TO VARIOUS AGENTS 7
737 TUBULOINTERSTITIAL NEPHRITIS 7
738 ULCER 7
739 UPPER-AIRWAY COUGH SYNDROME 7
740 VISUAL ACUITY REDUCED 7
741 ACCIDENTAL OVERDOSE 6
742 AGEUSIA 6
743 AMENORRHOEA 6
744 ANAL INCONTINENCE 6
745 APPETITE DISORDER 6
746 ATRIOVENTRICULAR BLOCK 6
747 BACTERIAL INFECTION 6
748 BLADDER CANCER 6
749 BLOOD VISCOSITY INCREASED 6
750 BRAIN NEOPLASM 6
751 CARDIAC VALVE DISEASE 6
752 CHOLECYSTITIS 6
753 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6
754 CONCUSSION 6
755 COVID-19 PNEUMONIA 6
756 DEMENTIA 6
757 DERMATITIS 6
758 DILATED CARDIOMYOPATHY 6
759 DRUG DIVERSION 6
760 DRUG DOSE OMISSION BY DEVICE 6
761 DRUG RESISTANCE 6
762 DRUG TOLERANCE 6
763 DYSLIPIDAEMIA 6
764 EXPOSURE TO UNSPECIFIED AGENT 6
765 FRACTURE 6
766 FULL BLOOD COUNT DECREASED 6
767 GASTROINTESTINAL PAIN 6
768 GLUCOSE TOLERANCE IMPAIRED 6
769 GROIN PAIN 6
770 HAEMANGIOMA 6
771 HANGOVER 6
772 HYPOKINESIA 6
773 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6
774 HYSTERECTOMY 6
775 ILEUS 6
776 IMPULSIVE BEHAVIOUR 6
777 INJECTION SITE ABSCESS 6
778 INTENTIONAL OVERDOSE 6
779 INTERVERTEBRAL DISC DISORDER 6
780 IRRITABLE BOWEL SYNDROME 6
781 JOINT DISLOCATION 6
782 LEUKOCYTOSIS 6
783 LIBIDO INCREASED 6
784 LUNG NEOPLASM MALIGNANT 6
785 LYMPHOCYTE COUNT DECREASED 6
786 MARITAL PROBLEM 6
787 METABOLIC DISORDER 6
788 MULTIPLE INJURIES 6
789 MUSCLE CONTRACTIONS INVOLUNTARY 6
790 MUSCLE MASS 6
791 NERVE COMPRESSION 6
792 PAIN OF SKIN 6
793 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6
794 PANCREATITIS ACUTE 6
795 PERIPHERAL VENOUS DISEASE 6
796 PRODUCT ADMINISTERED BY WRONG PERSON 6
797 PRODUCT LEAKAGE 6
798 PULMONARY CONGESTION 6
799 RECALLED PRODUCT 6
800 RED BLOOD CELL COUNT DECREASED 6
801 RESPIRATORY DISORDER 6
802 RESPIRATORY TRACT CONGESTION 6
803 SECRETION DISCHARGE 6
804 SKIN FISSURES 6
805 SKIN LACERATION 6
806 SMALL INTESTINAL OBSTRUCTION 6
807 SPINAL FRACTURE 6
808 SPUTUM DISCOLOURED 6
809 SUBDURAL HAEMATOMA 6
810 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 6
811 TENDON DISORDER 6
812 TESTICULAR PAIN 6
813 THERAPEUTIC PRODUCT EFFECT INCREASED 6
814 TOOTH FRACTURE 6
815 UNRESPONSIVE TO STIMULI 6
816 UPPER GASTROINTESTINAL HAEMORRHAGE 6
817 UPPER LIMB FRACTURE 6
818 WOUND 6
819 ABSCESS LIMB 5
820 ACCIDENT 5
821 ACCIDENTAL UNDERDOSE 5
822 ACUTE LUNG INJURY 5
823 ANORGASMIA 5
824 AORTIC THROMBOSIS 5
825 BEDRIDDEN 5
826 BLOOD PRESSURE FLUCTUATION 5
827 BODY TEMPERATURE INCREASED 5
828 BONE LOSS 5
829 BRAIN OEDEMA 5
830 CARDIAC VALVE FIBROELASTOMA 5
831 CAROTID ARTERY DISEASE 5
832 CEREBELLAR INFARCTION 5
833 CHRONIC FATIGUE SYNDROME 5
834 COMA 5
835 CORONARY ARTERY BYPASS 5
836 DENTAL CARIES 5
837 DEPENDENCE 5
838 DERMATITIS CONTACT 5
839 DIVERTICULUM 5
840 DIZZINESS POSTURAL 5
841 DRUG SCREEN POSITIVE 5
842 ENDOMETRIAL ADENOCARCINOMA 5
843 EPIDIDYMITIS 5
844 EYE HAEMORRHAGE 5
845 FEAR OF DEATH 5
846 FOOD POISONING 5
847 FOOT DEFORMITY 5
848 FOOT OPERATION 5
849 FRUSTRATION TOLERANCE DECREASED 5
850 GALLBLADDER DISORDER 5
851 GASTRITIS 5
852 GOITRE 5
853 HAEMOPTYSIS 5
854 HAEMORRHAGIC STROKE 5
855 HIDRADENITIS 5
856 HIP FRACTURE 5
857 HYPERCALCAEMIA 5
858 HYPERGLYCAEMIA 5
859 HYPERKERATOSIS 5
860 HYPOAESTHESIA ORAL 5
861 HYPOPHAGIA 5
862 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 5
863 INFUSION SITE PRURITUS 5
864 INJECTION RELATED REACTION 5
865 INJECTION SITE HAEMATOMA 5
866 INSULIN-LIKE GROWTH FACTOR DECREASED 5
867 INTERNATIONAL NORMALISED RATIO INCREASED 5
868 IRON DEFICIENCY ANAEMIA 5
869 JAUNDICE 5
870 JOINT STIFFNESS 5
871 LOWER LIMB FRACTURE 5
872 LYMPHOCYTE COUNT INCREASED 5
873 MALABSORPTION FROM INJECTION SITE 5
874 MALNUTRITION 5
875 MASS 5
876 MELANOCYTIC NAEVUS 5
877 MENISCUS INJURY 5
878 METABOLIC ENCEPHALOPATHY 5
879 MITRAL VALVE INCOMPETENCE 5
880 MONOCYTE COUNT INCREASED 5
881 MUSCLE DISORDER 5
882 NARCOLEPSY 5
883 NASAL DISCOMFORT 5
884 NECK SURGERY 5
885 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5
886 OPTIC ISCHAEMIC NEUROPATHY 5
887 ORAL CANDIDIASIS 5
888 ORAL DISCOMFORT 5
889 ORAL DISORDER 5
890 PARANASAL SINUS HYPERSECRETION 5
891 PARTNER STRESS 5
892 PERFORMANCE ENHANCING PRODUCT USE 5
893 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5
894 PERIPHERAL ISCHAEMIA 5
895 PERIPHERAL VASCULAR DISORDER 5
896 PHOTOPSIA 5
897 PORTAL VEIN THROMBOSIS 5
898 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5
899 PRODUCT CONTAMINATION MICROBIAL 5
900 PRODUCT LABEL CONFUSION 5
901 PRODUCT PACKAGING ISSUE 5
902 PRODUCT SOLUBILITY ABNORMAL 5
903 RASH PAPULAR 5
904 RENAL FAILURE ACUTE 5
905 RENAL HAEMORRHAGE 5
906 RENAL INFARCT 5
907 RHINITIS 5
908 SARS-COV-2 TEST POSITIVE 5
909 SENSORY DISTURBANCE 5
910 SKIN BURNING SENSATION 5
911 SPLENOMEGALY 5
912 SUBARACHNOID HAEMORRHAGE 5
913 SUSPECTED PRODUCT QUALITY ISSUE 5
914 TENDONITIS 5
915 TENSION 5
916 TESTICULAR FAILURE 5
917 TONGUE DISCOMFORT 5
918 TOOTHACHE 5
919 TRIGGER FINGER 5
920 TRISMUS 5
921 URINARY TRACT DISORDER 5
922 VENOUS THROMBOSIS 5
923 WRIST FRACTURE 5
924 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5
925 ABDOMINAL HERNIA 4
926 ABDOMINAL OPERATION 4
927 ABDOMINAL PAIN LOWER 4
928 ABDOMINAL TENDERNESS 4
929 ABNORMAL LOSS OF WEIGHT 4
930 ACCIDENTAL EXPOSURE 4
931 ADMINISTRATION SITE PAIN 4
932 ADRENAL DISORDER 4
933 ANAPHYLACTIC SHOCK 4
934 ANDROGEN DEFICIENCY 4
935 ANEURYSM 4
936 ANXIETY DISORDER 4
937 AORTIC DISSECTION 4
938 APHONIA 4
939 APNOEA 4
940 APPARENT DEATH 4
941 ARTERIAL THROMBOSIS 4
942 ARTHROPOD BITE 4
943 ATAXIA 4
944 AUTOIMMUNE DISORDER 4
945 BLOOD ALKALINE PHOSPHATASE INCREASED 4
946 BLOOD CALCIUM INCREASED 4
947 BLOOD CREATININE DECREASED 4
948 BLOOD DISORDER 4
949 BLOOD GLUCOSE ABNORMAL 4
950 BLOOD PROLACTIN INCREASED 4
951 BLOOD URINE PRESENT 4
952 BRAIN STEM INFARCTION 4
953 BUNDLE BRANCH BLOCK RIGHT 4
954 CARBON DIOXIDE DECREASED 4
955 CARBON DIOXIDE INCREASED 4
956 CARDIAC PACEMAKER INSERTION 4
957 CATAPLEXY 4
958 CEREBRAL ISCHAEMIA 4
959 CHOLESTATIC LIVER INJURY 4
960 CHONDROPATHY 4
961 CLOSTRIDIUM DIFFICILE COLITIS 4
962 CLOSTRIDIUM DIFFICILE INFECTION 4
963 CORONARY ARTERIAL STENT INSERTION 4
964 CRANIOCEREBRAL INJURY 4
965 DEPRESSED LEVEL OF CONSCIOUSNESS 4
966 DERMAL CYST 4
967 DEVICE DIFFICULT TO USE 4
968 DEVICE USE ERROR 4
969 DIALYSIS 4
970 DIVERTICULUM INTESTINAL 4
971 DRUG PRESCRIBING ERROR 4
972 DYSPHEMIA 4
973 DYSPHORIA 4
974 EAR PAIN 4
975 EATING DISORDER 4
976 ECCHYMOSIS 4
977 EJACULATION DISORDER 4
978 EJECTION FRACTION DECREASED 4
979 EMBOLIC STROKE 4
980 EMERGENCY CARE 4
981 ENDOCARDITIS 4
982 ENDOMETRIAL CANCER 4
983 EOSINOPHIL COUNT INCREASED 4
984 EPSTEIN-BARR VIRUS INFECTION 4
985 ESCHERICHIA INFECTION 4
986 EYE INFECTION 4
987 EYE OPERATION 4
988 FEELING OF BODY TEMPERATURE CHANGE 4
989 FEMUR FRACTURE 4
990 FINE MOTOR SKILL DYSFUNCTION 4
991 FISTULA 4
992 FLANK PAIN 4
993 FLUID INTAKE REDUCED 4
994 FORMICATION 4
995 GASTRIC DISORDER 4
996 GASTRIC ULCER 4
997 GASTROENTERITIS 4
998 GASTROINTESTINAL INFECTION 4
999 GASTROINTESTINAL MOTILITY DISORDER 4